Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C

Jan Martin Berke1, Denis Fenistein, Frederik Pauwels

  • 1Tibotec BVBA, 2800 Mechelen, Belgium. jberke@its.jnj.com